Provided by Tiger Fintech (Singapore) Pte. Ltd.

INDIVIOR PLC

11.56
+0.80007.43%
Post-market: 11.560.00000.00%18:33 EDT
Volume:1.46M
Turnover:16.37M
Market Cap:1.44B
PE:-31.86
High:11.58
Open:10.76
Low:10.52
Close:10.76
Loading ...

Indivior (LON:INDV) shareholder returns have been enviable, earning 366% in 5 years

Simply Wall St.
·
11 Dec 2024

Indivior’s Strategic Share Repurchase Initiative

TIPRANKS
·
26 Nov 2024

Addex Therapeutics Ltd (ADXN) Q3 2024 Earnings Call Highlights: Strategic Partnerships and ...

GuruFocus.com
·
23 Nov 2024

Indivior shares Sublocade trial findings at CSAM conference

TIPRANKS
·
20 Nov 2024

Rapid Initiation with Once-monthly SUBLOCADE® Superior to Standard Initiation for Treating Opioid Use Disorder, Including in Fentanyl-Positive Patients, According to Data Presented at CSAM 2024

PR Newswire
·
20 Nov 2024

Indivior PLC Executes Strategic Share Repurchase

TIPRANKS
·
19 Nov 2024

Indivior’s Voting Rights Shift with Madison Avenue

TIPRANKS
·
18 Nov 2024

Howard Marks Adjusts Portfolio, Major Moves in TORM PLC and Talen Energy

GuruFocus.com
·
15 Nov 2024

Deerfield’s Strategic Stake Acquisition in Indivior

TIPRANKS
·
11 Nov 2024

Indivior Responds to Publication of a Letter by Oaktree Capital Management to the Board of Indivior

PR Newswire
·
08 Nov 2024

Indivior jumps amid takeover speculation

seekingalpha
·
07 Nov 2024

BRIEF-Indivior PLC Enters $400 Million Senior Secured Notes Agreeement

Reuters
·
05 Nov 2024

Indivior Boosts Shareholder Value with Repurchase Program

TIPRANKS
·
05 Nov 2024

Indivior Highlights Growing Body of Data on SUBLOCADE® (buprenorphine once-monthly extended-release injection) Helping Patients Achieve Long-Term Recovery from Opioid Use Disorder during Substance Abuse Prevention Month

PR Newswire
·
31 Oct 2024